Resistance to activated protein C activity of an anti‐/2 ‐glycoprotein I antibody in the presence of β‐glycoprotein I

British Journal of Haematology

Volumn 90, Issue 1, 1995, Pages 204-206

  MATSUDA, Juzo ^a   GOTOH, MORITAKA ^a   GOHCHI, KENGO ^a   KAWASUGI, KAZUO ^a   TSUKAMOTO, MIYO ^a   SAITOH, NORIKO ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

glycoprotein I; activated protein C resistance; anti 2 glycoprotein I antibody; anti cardiolipin antibody; lupus anticoagulant

Indexed keywords

ACTIVATED PROTEIN C; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DRUG RESISTANCE; HUMAN; PRIORITY JOURNAL; VEIN THROMBOSIS;

ANTIBODIES, ANTICARDIOLIPIN; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FALSE POSITIVE REACTIONS; GLYCOPROTEINS; HUMAN; IMMUNOGLOBULIN G; PROTEIN C; THROMBOPHLEBITIS;

EID: 0029070780     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1995.tb03401.x     Document Type: Article

References (13)

1. Mutation in blood coagulation factor V associated with resistance to activated protein C
2. Familial thrombosis due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C
3. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V
4. Resistance to activated protein C in nine thrombophilia families: interference in a protein S functional assay
5. Anticoagulant protein C pathway defective in majority of thrombophilic patients
6. Influence of lupus anticoagulant on a commercially available kit for APC‐resistance
7. Resistance to activated protein C
8. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study
9. 2 ‐glycoprotein I‐dependent antiphospholipid antibodies
10. Anticardiolipin antibodies recognize β‐glycoprotein structure altered by interacting with an oxygen modified solid phase surface
11. Binding of (32‐glycoprotein I to platelets: effect of adenilate cyclase activity
12. Resistance to activated protein C as a basis for venous thrombosis
13. 2‐glycoprotein I antibodies with lupus‐type circulating anticoagulant and thrombosis in systemic lupus erythematosus